Fineline Cube

Follow:
14467 Articles
Policy / Regulatory

NHSA Preliminary Review Identifies Potential NRDL Additions, Including Novel Therapies and ADCs

CompanyDigital

Shanghai Pharmaceuticals’ SH-INNO Incubator to Drive Biopharmaceutical Innovation and Collaboration

CompanyDeals

Hygeia Healthcare Holdings Acquires Chang An Hospital in Deal Valued at RMB 1.66 Billion

CompanyDrug

Changshan Biochemical Gets Marketing Nod for Enoxaparin in Kyrgyzstan for Venous Thromboembolic Diseases

CompanyDrug

Haisco Pharmaceutical’s PDE4B Inhibitor HSK44459 Gets NMPA Green Light for Interstitial Lung Disease Clinical Trial

CompanyMedical Device

Vazyme Biotech Secures NMPA Nod for Two RSV Antigen Detection Kits

CompanyDeals

Eisai and SEED Therapeutics Join Forces on Molecular Glue Degraders for Neurodegeneration and Cancer

CompanyDrug

Servier’s Voranigo Receives FDA Nod for IDH Inhibitor as Brain Tumor Treatment

Company

Organon’s Q2 2024 Revenues Grow 2% YOY, Sets Sights on Fertility Business Rebound in 2025

CompanyDrug

Akeso Biopharma Initiates Phase III Clinical Trial for Cadonilimab in Hepatocellular Carcinoma

Policy / Regulatory

China’s NMPA Proposes New Rules for Export Drug Manufacturing and Management

CompanyDeals

JiAnTeBo and Sanyou Biopharmaceuticals Join Forces to Discover Metabolic Disease Targets and Develop Agonistic Antibodies